ABCDx
Transforming brain injury care by the use of biomarker panel tests for the assessment and indication in patients. Learn more
Launch date
Employees
Company register number CH-660.2.068.014-1
Geneva Canton of Geneva (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
N/A | Grant | ||
N/A | N/A | Seed | |
N/A | Early VC | ||
* | €2.8m | Grant | |
Total Funding | €2.8m |
Related Content
Recent News about ABCDx
EditMore about ABCDx
EditDeveloper of a compact medical device created to diagnose a mild traumatic brain injury. The company's device analyzes the level of proteins in the blood using a single drop of blood to diagnose the probability of a mild traumatic brain injury within ten minutes, enabling healthcare professionals to early detection of brain injuries, quick clinical decision-making and significantly lower expense for the majority of patients.
Keywords: Healthcare Devices, Services, Supplies, Blood-Based Biomarker, Blood-Based Biomarker Test, Brain Biomarker, Brain Biomarkers, Brain Injury Detection, Traumatic Brain.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.